Where innovative Medical Go-To-Market Success is the rule! 

Want to Learn or See More? Click here

Synergistic Marketing, founded in 1990 by Mark Lutvak, is a successful, growing and profitable sales and marketing contracting firm and consultancy. We are dedicated to serving Small Emerging businesses that own or possess Medical Technology or Medical Device IP. We support our clients with a go-to-market strategy that takes advantage of our extensive network of medical industry companies as well as our extensive list of contacts who are our Corporate Partners.

Want to Learn or See More? Click here

 

Medical Technology and Device News Title

  • May 2, 2016:

    Many congenital, acquired, and degenerative diseases of the eye cause decreased focus, accommodation, or retinal image degradation. Google’s latest move to nudge its way into the healthcare market, includes filing a patent for an injectable intra-ocular device.
    - fluid in the lens capsule to make a coupling between the capsule and device
    - Detect forces exerted by eye on lens capsule applied to the device via the lens capsule
    - Control electronic lens’s optical power based on detected accommodation forces Full Story

  • April 29, 2016:

    A team of researchers from The Hong Kong Polytechnic University and Zhejiang University in China report integrating fiber optic glucose sensors into a microfluidic chip to create portable, high-performance, low-cost devices for measuring glucose levels. In a paper published this week in the journal Biomedical Optics Express, from The Optical Society (OSA). Now, researchers are working to create ultrasensitive lab-on-a-chip devices to quickly measure glucose concentrations with the goal of developing device for early diagnosis and prevent of diabetes.Full Story

  • April 29, 2016:

    Electronics that dissolve over time are great for localized drug delivery. Jikui Luo, Xiaozhi Wang and colleagues have reported in the journal ACS Applied Materials & Interfaces they have created a dissolvable device component out of egg proteins, magnesium and tungsten. In water, the electrodes and albumin dissolved in two to 10 hours in the lab. The rest of the chip took about three days to break down, leaving minimal residues behind.Full Story

  • April 27, 2016:

    The delivery of Medical Supplies by drone is gaining traction with a patent application from Google and a partnership between a Silicon Valley startup called Zipline and the Rwandan government. Google’s patent describes a system that would allow people in trouble to call for a drone that would deliver the necessary equipment, such as a defibrillator or insulin, and contact the nearest dispatcher to send an ambulance to the location. Zipline is planning to deliver medicine, blood, and other medical supplies to remote clinics throughout Rwanda starting in July using 15 plane-like drones.Full Story

  • April 15, 2016:

    Medtronic announced that the FDA has cleared Pillcam COLON 2, a swallowable camera approved for general use in colon exams. The PillCam capsule- a vitamin-sized capsule endoscope is taken orally and does not require sedation, anesthesia or radiation, which makes it a more convenient procedure than other invasive colon exams. The PillCam COLON 2 capsule is the only non-invasive diagnostic test that directly visualizes the colon for the evaluation of polyps in patients who are at major risks for colonoscopy or moderate sedation.Full Story

  • April 13, 2016:

    Yale University has developed a nanogel immunotherapy delivery system which can be used for multiple combinations of drugs for many different cancers and some immune disorders. The platform is designed to deliver multiple drugs with different chemical properties. A single particle can carry hundreds of drug molecules that concentrate in the tumor, increasing the efficacy of the drug combination while decreasing its toxicity. The delivery system is heading toward its first phase of clinical trials for a possible new treatment for cancer.Full Story

  • April 12, 2016:

    Pfizer Inc. and IBM announced a first-of-its-kind research collaboration to develop innovative remote monitoring solutions aimed at transforming how clinicians deliver care to patients suffering from Parkinson’s disease. The two companies will convene an external advisory board of patient groups, advocacy organizations, clinicians, and neuroscientists for guidance so as to move into initial clinical testing quickly. The experimental approach will rely on a system of sensors, mobile devices, and machine learning to provide real-time, around-the-clock disease symptom information to clinicians and researchers. The approach will create a better understanding of a patient’s disease progression and response to medication.Full Story

  • April 7, 2016:

    “The Edema Guard Monitor alerts patients to an increase in fluid in the lungs before they have symptoms” said Michael K. Shochat, M.D. , of Hillel Yaffe Heart Institute in Hadera, Israel, president of RS Medical Monitoring, and lead author of a study presented at the American College of Cardiology's 65th Annual Scientific Session. The study reported that in patients with heart failure, use of an investigational device that monitors the accumulation of fluid in the lungs appeared to cut heart failure-related hospitalizations by more than half.Full Story